Towards preventive medicine

[1]  Tariq Ismail,et al.  Proteomic profiling of urine for the detection of colon cancer , 2008, Proteome Science.

[2]  R. Bernards,et al.  Enabling personalized cancer medicine through analysis of gene-expression patterns , 2008, Nature.

[3]  Byung Kwan Park,et al.  Gene expression profiling for the prediction of lymph node metastasis in patients with cervical cancer , 2007, Cancer science.

[4]  Erik Sahai,et al.  Illuminating the metastatic process , 2007, Nature Reviews Cancer.

[5]  J. Kling.  Diagnosis or drug? , 2007 .

[6]  P. Sebastiani,et al.  Airway epithelial gene expression in the diagnostic evaluation of smokers with suspect lung cancer , 2007, Nature Medicine.

[7]  G. Sherlock,et al.  The prognostic role of a gene signature from tumorigenic breast-cancer cells. , 2007, The New England journal of medicine.

[8]  R. Schlapbach,et al.  Casting light on molecular events underlying anti-cancer drug treatment: what can be seen from the proteomics point of view? , 2006, Cancer treatment reviews.

[9]  Sandra Kraljević,et al.  Navigare necessere est , 2005 .

[10]  Ruud H. Brakenhoff,et al.  Dissecting the metastatic cascade , 2004, Nature Reviews Cancer.

[11]  O. Kallioniemi.  Medicine: Profile of a tumour , 2004, Nature.

[12]  Michael J Korenberg,et al.  On predicting medulloblastoma metastasis by gene expression profiling. , 2004, Journal of proteome research.

[13]  L. Liotta,et al.  Use of proteomic analysis to monitor responses to biological therapies , 2004, Expert opinion on biological therapy.

[14]  H. Hampel,et al.  Advances in the development of biomarkers for Alzheimer’s disease: from CSF total tau and Aβ1–42 proteins to phosphorylated tau protein , 2003, Brain Research Bulletin.

[15]  D. Hochstrasser,et al.  A panel of cerebrospinal fluid potential biomarkers for the diagnosis of Alzheimer's disease , 2003, Proteomics.

[16]  Joel G. Pounds,et al.  Proteomic Characterization of Nipple Aspirate Fluid: Identification of Potential Biomarkers of Breast Cancer , 2003, Breast Cancer Research and Treatment.

[17]  P. Lewczuk,et al.  The amyloid-β (Aβ) peptide pattern in cerebrospinal fluid in Alzheimer's disease: evidence of a novel carboxyterminally elongated Aβ peptide , 2003 .

[18]  C. Cordon-Cardo,et al.  A multigenic program mediating breast cancer metastasis to bone. , 2003, Cancer cell.

[19]  D. Chan,et al.  Characterization of Renal Allograft Rejection by Urinary Proteomic Analysis , 2003, Annals of surgery.

[20]  M. Marton,et al.  A gene-expression signature as a predictor of survival in breast cancer. , 2002, The New England journal of medicine.

[21]  C. Perou,et al.  Molecular portraits and the family tree of cancer , 2002, Nature Genetics.

[22]  E. Petricoin,et al.  Clinical proteomics: translating benchside promise into bedside reality , 2002, Nature Reviews Drug Discovery.

[23]  D. Fishman,et al.  Three-dimensional power Doppler ultrasound improves the diagnostic accuracy for ovarian cancer prediction. , 2001, Gynecologic oncology.

[24]  Elise C. Kohn,et al.  The microenvironment of the tumour–host interface , 2001, Nature.

[25]  Lance A. Liotta,et al.  Cancer: An attractive force in metastasis , 2001, Nature.

[26]  Lance A. Liotta,et al.  Cancer: Checkpoint for invasion , 2000, Nature.

[27]  Ash A. Alizadeh,et al.  Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling , 2000, Nature.

[28]  Francis H. Zenie,et al.  Accelerating Drug Discovery , 1994, Bio/Technology.

[29]  C. Blakemore,et al.  Present Status and Future Strategy for Medical Research in Europe , 2007 .

[30]  L. Staudt,et al.  Gene expression profiling of lymphoid malignancies. , 2002, Annual review of medicine.

[31]  E. Petricoin,et al.  Use of proteomic patterns in serum to identify ovarian cancer , 2002, The Lancet.